HCA Healthcare, Inc. (NYSE:HCA), with a forward P/E of 12.27 and upside potential of 38.4%, is among the top 10 lowest forward P/E stocks in the S&P 500.
HCA Healthcare, Inc. (NYSE:HCA) is navigating a cautious macro backdrop for healthcare while continuing to invest in long-term workforce development.
On June 4, 2026, Bernstein lowered its price target on HCA Healthcare, Inc. (NYSE:HCA) to $413 from $503, keeping a “Market Perform” rating. The firm said it views HCA as much more attractive at current valuation levels but does not expect a near-term catalyst to improve the outlook. Bernstein projects EBITDA growth of 2.8% in 2026 and 4.6% in 2027, citing lower insurance coverage from policy changes and a lack of growth in state-directed payments as the primary headwinds.
Meanwhile, on May 27, 2026, HCA Healthcare, Inc. (NYSE:HCA) announced an agreement to acquire The College of Health Care Professions (CHCP), one of the largest allied healthcare training providers in Texas. CHCP educates more than 8,000 students annually across 10 campuses in Texas and online, offering over 20 accredited programs, including Medical Assisting, Sonography, Surgical Technology, and Radiologic Technology. Financial terms were not disclosed.
The deal builds on HCA’s existing education portfolio.
HCA Healthcare, Inc. (NYSE:HCA) acquired majority ownership of Galen College of Nursing in 2020 and has since expanded it to 25 campuses nationwide. HCA also operates the Research College of Nursing in Kansas City and the HCA Florida Mercy College of Nursing in Miami. Eric Bing will continue to lead CHCP as Chancellor and CEO following the close, subject to regulatory approval.
HCA Healthcare, Inc. (NYSE:HCA) is a health services company that operates hospitals, urgent care facilities, freestanding surgery centers, emergency care facilities, walk-in clinics, diagnostic and imaging centers, comprehensive rehabilitation and physical therapy centers, radiation and oncology therapy centers, and several other facilities. The company operates general and acute care hospitals that offer medical and surgical services.
While we acknowledge the risk and potential of HCA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than HCA and that has 10,000% upside potential, check out our report about this cheapest AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
Disclosure: None. Follow Insider Monkey on Google News.
